Literature DB >> 34233521

Association of genetic variants rs641153 (CFB), rs2230199 (C3), and rs1410996 (CFH) with age-related macular degeneration in a Brazilian population.

Jamil M Neto1, Marina Gm Viturino1, Galina Ananina2, Flávia F Bajano2, Sueli M da S Costa2, Alicia B Roque1, Gessica Fs Borges1, Raissa Franchi2, Priscila Hh Rim1, Flávio M Medina3, Fernando F Costa4, Mônica B de Melo2, José Pc de Vasconcellos1.   

Abstract

This study aimed to investigate the association among genetic variants of the complement pathway CFB R32Q (rs641153), C3 R102G (rs2230199), and CFH (rs1410996) with age-related macular degeneration (AMD) in a sample of the Brazilian population. In a case-control study, 484 AMD patients were classified according to the clinical age-related maculopathy grading system (CARMS) and compared to 479 unrelated controls. The genetic variants rs1410996 of complement H (CFH), rs641153 of complement factor B (CFB), and rs2230199 of complement 3 (C3) were evaluated through polymerase chain reaction (PCR) and direct sequencing. The associations between single nucleotide polymorphisms (SNPs) and AMD, adjusted by age, were assessed by using logistic regression models. A statistically significant association was observed between AMD risk and rs2230199 variant with an OR of 2.01 (P  = 0.0002) for CG individuals compared to CC individuals. Regarding the comparison of advanced AMD versus the control group, the OR was 2.12 (P = 0.0036) for GG versus AA genotypes for rs1410996 variant. Similarly, the OR for rs2230199 polymorphism was 2.3034 (P  = 5.47e-05) when comparing CG individuals to CC carriers. In contrast, the rs641153 variant showed a significant protective effect against advanced AMD for GA versus GG genotype (OR = 0.4406; P  = 0.0019). When comparing wet AMD versus controls, a significant association was detected for rs1410996 variant (OR = 2.16; P  = 0.0039) comparing carriers of the homozygous GG versus AA genotype, as well as in the comparisons of GG (OR = 3.0713; P  = 0.0046) and CG genotypes (OR = 2.2249; P  = 0.0002) versus CC genotype for rs2230199 variant, respectively. The rs641153 variant granted a significant protective effect against wet AMD for GA versus GG genotypes (OR = 0.4601; P  = 0.0044). Our study confirmed the risk association between rs2230199 and rs1410996 variants and AMD, and the protective role against AMD for rs641153 variant.

Entities:  

Keywords:  Complement pathway; age-related macular degeneration; genetic risk; rs1410996; rs2230199; rs641153

Mesh:

Substances:

Year:  2021        PMID: 34233521      PMCID: PMC8581831          DOI: 10.1177/15353702211024543

Source DB:  PubMed          Journal:  Exp Biol Med (Maywood)        ISSN: 1535-3699


  43 in total

1.  CFH haplotypes without the Y402H coding variant show strong association with susceptibility to age-related macular degeneration.

Authors:  Mingyao Li; Pelin Atmaca-Sonmez; Mohammad Othman; Kari E H Branham; Ritu Khanna; Michael S Wade; Yun Li; Liming Liang; Sepideh Zareparsi; Anand Swaroop; Gonçalo R Abecasis
Journal:  Nat Genet       Date:  2006-08-27       Impact factor: 38.330

2.  Cognitive impairment in age-related macular degeneration and geographic atrophy.

Authors:  Se Joon Woo; Kyu Hyung Park; Jeeyun Ahn; Jin Yeong Choe; Hyeon Jeong; Ji Won Han; Tae Hui Kim; Ki Woong Kim
Journal:  Ophthalmology       Date:  2012-06-15       Impact factor: 12.079

3.  Risk of falls, injurious falls, and other injuries resulting from visual impairment among older adults with age-related macular degeneration.

Authors:  Joanne M Wood; Philippe Lacherez; Alex A Black; Michael H Cole; Mei Ying Boon; Graham K Kerr
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-07-07       Impact factor: 4.799

Review 4.  Age-related macular degeneration: a perspective on genetic studies.

Authors:  N Patel; T Adewoyin; N V Chong
Journal:  Eye (Lond)       Date:  2007-05-11       Impact factor: 3.775

5.  Structural and functional analysis of the complement component factor H with the use of different enzymes and monoclonal antibodies to factor H.

Authors:  J Alsenz; T F Schulz; J D Lambris; R B Sim; M P Dierich
Journal:  Biochem J       Date:  1985-12-15       Impact factor: 3.857

6.  Variation in factor B (BF) and complement component 2 (C2) genes is associated with age-related macular degeneration.

Authors:  Bert Gold; Joanna E Merriam; Jana Zernant; Lisa S Hancox; Andrew J Taiber; Karen Gehrs; Kevin Cramer; Julia Neel; Julie Bergeron; Gaetano R Barile; R Theodore Smith; Gregory S Hageman; Michael Dean; Rando Allikmets
Journal:  Nat Genet       Date:  2006-03-05       Impact factor: 38.330

Review 7.  The association between complement component 2/complement factor B polymorphisms and age-related macular degeneration: a HuGE review and meta-analysis.

Authors:  Ammarin Thakkinstian; Mark McEvoy; Usha Chakravarthy; Subhabrata Chakrabarti; Gareth J McKay; Euijung Ryu; Giuliana Silvestri; Inderjeet Kaur; Peter Francis; Takeshi Iwata; Masakazu Akahori; Astrid Arning; Albert O Edwards; Johanna M Seddon; John Attia
Journal:  Am J Epidemiol       Date:  2012-08-05       Impact factor: 4.897

8.  C3 R102G polymorphism increases risk of age-related macular degeneration.

Authors:  Kylee L Spencer; Lana M Olson; Brent M Anderson; Nathalie Schnetz-Boutaud; William K Scott; Paul Gallins; Anita Agarwal; Eric A Postel; Margaret A Pericak-Vance; Jonathan L Haines
Journal:  Hum Mol Genet       Date:  2008-03-06       Impact factor: 6.150

Review 9.  Quality of life in age-related macular degeneration: a review of the literature.

Authors:  Jan Mitchell; Clare Bradley
Journal:  Health Qual Life Outcomes       Date:  2006-12-21       Impact factor: 3.186

10.  Prevalence and causes of visual impairment in a Brazilian population: the Botucatu Eye Study.

Authors:  Silvana Artioli Schellini; Shane R Durkin; Erika Hoyama; Flavio Hirai; Ricardo Cordeiro; Robert J Casson; Dinesh Selva; Carlos Roberto Padovani
Journal:  BMC Ophthalmol       Date:  2009-08-19       Impact factor: 2.209

View more
  1 in total

Review 1.  Molecular Genetic Mechanisms in Age-Related Macular Degeneration.

Authors:  Aumer Shughoury; Duriye Damla Sevgi; Thomas A Ciulla
Journal:  Genes (Basel)       Date:  2022-07-12       Impact factor: 4.141

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.